FMOD and pachyonychia congenita: Recently, The Cancer Genome Atlas prostate adenocarcinoma mRNA expression data were analyzed using a recursive partitioning method and it was found that low expression of the FMOD gene is associated with worse progression-free survival of PC patients, with a Gleason score lower than 9 [78].